Steven Cohen's TENX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 556,761 shares of Tenax Therapeutics, Inc. (TENX) worth $8.1 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in TENX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 110,550 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tenax Therapeutics (TENX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenax Therapeutics (TENX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +22,796 | Add 4.27% | 556,761 | $14.55 |
| Q1 2026 | +110,550 | Add 26.11% | 533,965 | $15.99 |
| Q4 2025 | +423,415 | New Buy | 423,415 | $12.19 |
Steven Cohen's Tenax Therapeutics Investment FAQs
Steven Cohen first purchased Tenax Therapeutics, Inc. (TENX) in Q4 2025, acquiring 423,415 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tenax Therapeutics, Inc. (TENX) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Tenax Therapeutics, Inc. (TENX) was in Q4 2025, adding 423,415 shares worth $5.16 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 556,761 shares of Tenax Therapeutics, Inc. (TENX), valued at approximately $8.1 M.
As of the Q2 2026 filing, Tenax Therapeutics, Inc. (TENX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tenax Therapeutics, Inc. (TENX) was 556,761 shares, as reported at the end of Q2 2026.